Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 13Thoracic 1Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Neuroblastoma 5Colonic Neoplasms 5Pancreatic Neoplasms 3Osteosarcoma 3Melanoma 3Medulloblastoma 3Glioblastoma 3Familial ependymoma 3Stomach Neoplasms 2Rectal Neoplasms 2Prostatic Neoplasms 2Optic Nerve Glioma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neoplasms 2Neoplasm Metastasis 2Nasopharyngeal Neoplasms 2Multiple Myeloma 2Gallbladder Neoplasms 2Colorectal Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Astrocytoma 2Wilms Tumor 1Vipoma 1Thyroid Neoplasms 1Testicular Neoplasms 1Teratoma 1Squamous Cell Carcinoma of Head and Neck 1Somatostatinoma 1

Interventions

Docetaxel 7Radiotherapy 6Filgrastim 6Cisplatin 4Peripheral Blood Stem Cell Transplantation 3Chemotherapy, Adjuvant 3Carboplatin 3selpercatinib 2sargramostim 2Thiotepa 2Radiotherapy, Intensity-Modulated 2Paclitaxel 2Nivolumab 2Gemcitabine 2Etoposide 2Drug Therapy 2Doxorubicin 2Capecitabine 2Biopsy 2Acupuncture Therapy 2vocimagene amiretrorepvec 1vandetanib 1ulixertinib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1tanespimycin 1spartalizumab 1pentetreotide 1pazopanib 1oncogene protein E7, Human papillomavirus type 16 1oblimersen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Head and Neck Neoplasms × Oxaliplatin × CNS × Clear all
NCT00448552 2016-12-15

Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer

University of Miami

Phase 2 Completed
30 enrolled
CNSHead & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡